Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives... Show more
a developer of small molecule pharmaceutical products
Industry Biotechnology
The 50-day moving average for TBPH moved above the 200-day moving average on October 26, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
TBPH moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TBPH crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for TBPH entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.